The abstract is read at the publisher; the summary is JClub's.
In 350 consecutive patients with obstructive hypertrophic cardiomyopathy, septal myectomy combined with anterior mitral leaflet secondary chordal cutting yielded 96% 6-year overall survival and low surgical mortality (0.6%).
- Why it matters: Uncertainty remains about the future role of surgery for obstructive HCM as medical options evolve, yet some patients remain highly symptomatic despite therapy.
- What they did: The team followed patients operated on at their center over 5 years, with median follow-up of 5.6 years (Q1–Q3: 4.2–6.3), assessing survival, NYHA class, and echocardiographic outcomes.
- The result: At last evaluation, 79% were NYHA class I and ≥95% had no residual left ventricular outflow gradient, clinically significant mitral regurgitation, or impaired systolic function, supporting durable long-term hemodynamic and clinical benefit.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.